scispace - formally typeset
J

Jinling Wang

Researcher at St. Jude Children's Research Hospital

Publications -  10
Citations -  1686

Jinling Wang is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Mutant & Cell cycle. The author has an hindex of 9, co-authored 10 publications receiving 1588 citations.

Papers
More filters
Journal ArticleDOI

Puma is an essential mediator of p53-dependent and -independent apoptotic pathways

TL;DR: It is reported that Puma is essential for hematopoietic cell death triggered by ionizing radiation, deregulated c-Myc expression, and cytokine withdrawal, and required for IR-induced death throughout the developing nervous system and accounts for nearly all of the apoptotic activity attributed to p53 under these conditions.
Journal ArticleDOI

Activation of c-myc Gene Expression by Tumor-Derived p53 Mutants Requires a Discrete C-Terminal Domain

TL;DR: It is suggested that it may be possible to selectively inhibit mutant p53 gain of function and consequently reduce the tumorigenic potential of cancer cells.
Journal ArticleDOI

Regulation of Insulin-like Growth Factor-Mammalian Target of Rapamycin Signaling by MicroRNA in Childhood Adrenocortical Tumors

TL;DR: Results reveal a novel mechanism of regulation of mTOR signaling by miRNAs, and they lay the groundwork for clinical evaluation of drugs inhibiting the mTOR pathway for treatment of adrenocortical cancer.
Journal ArticleDOI

Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways

TL;DR: These findings functionally link the Jak signaling pathway to suppression of p53-mediated cell death by cytokines and demonstrate that the apoptotic and growth arrest responses to DNA damage in hematopoietic cells are modulated by distinct, cytokine specific signal transduction pathways.